Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2.

CD4-Positive T-Lymphocytes / immunology Evolution, Molecular HEK293 Cells HIV Infections / immunology HIV-1 / classification HIV-2 / genetics HLA-C Antigens / genetics Host-Pathogen Interactions / immunology Human Immunodeficiency Virus Proteins / genetics Humans Killer Cells, Natural / immunology T-Lymphocytes, Cytotoxic / immunology Viral Regulatory and Accessory Proteins / genetics vif Gene Products, Human Immunodeficiency Virus / genetics
HIV-1 HIV-2 HLA-C SIV Vif Vpu

Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
14 07 2020
Historique:
entrez: 16 7 2020
pubmed: 16 7 2020
medline: 16 7 2021
Statut: epublish

Résumé

HLA-C-mediated antigen presentation induces the killing of human immunodeficiency virus (HIV)-infected CD4

Identifiants

DOI: 10.1128/mBio.00782-20 PMID: 32665270 PMC: PMC7360927
pubmed: 32665270
pii: mBio.00782-20
doi: 10.1128/mBio.00782-20
pmc: PMC7360927
pii:
doi:

Substances chimiques

HLA-C Antigens 0
Human Immunodeficiency Virus Proteins 0
Viral Regulatory and Accessory Proteins 0
vif Gene Products, Human Immunodeficiency Virus 0
vif protein, Human immunodeficiency virus 2 0
vpu protein, Human immunodeficiency virus 1 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI126620
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI150590
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI050529
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI120810
Pays : United States
Organisme : CIHR
ID : 352417
Pays : Canada
Organisme : NIAID NIH HHS
ID : P30 AI045008
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI114266
Pays : United States

Informations de copyright

Copyright © 2020 Hopfensperger et al.

Références

Nature. 2002 Aug 8;418(6898):646-50
pubmed: 12167863
J Biol Chem. 2001 May 11;276(19):15920-8
pubmed: 11278695
Cell Rep. 2015 Feb 3;10(4):586-99
pubmed: 25620704
Nat Genet. 2009 Dec;41(12):1290-4
pubmed: 19935663
Immunogenetics. 2015 Aug;67(8):437-45
pubmed: 26009014
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6626-33
pubmed: 23542380
J Virol. 1991 Aug;65(8):4051-6
pubmed: 1712857
J Virol. 2018 Mar 14;92(7):
pubmed: 29321314
Immunol Rev. 2001 Oct;183:41-64
pubmed: 11782246
Nature. 1990 May 24;345(6273):356-9
pubmed: 2188136
Nucleic Acids Res. 1988 Nov 25;16(22):10881-90
pubmed: 2849754
PLoS Pathog. 2015 Aug 28;11(8):e1005141
pubmed: 26317613
PLoS Pathog. 2017 Aug 31;13(8):e1006598
pubmed: 28859166
Cell Host Microbe. 2018 Jan 10;23(1):110-120.e7
pubmed: 29324226
Eur J Immunol. 2014 Oct;44(10):2938-48
pubmed: 25043727
J Exp Med. 2010 Jan 18;207(1):39-49
pubmed: 20038599
AIDS Res Hum Retroviruses. 1996 Jul 20;12(11):1031-40
pubmed: 8827219
EMBO J. 1997 Aug 1;16(15):4531-9
pubmed: 9303297
Elife. 2019 Feb 05;8:
pubmed: 30717826
Mol Cell Biol. 1987 Jan;7(1):379-87
pubmed: 3031469
Nucleic Acids Res. 2020 Jan 8;48(D1):D948-D955
pubmed: 31667505
AIDS. 1999 Oct 22;13(15):2033-42
pubmed: 10546855
PLoS Med. 2015 Nov 17;12(11):e1001900; discussion e1001900
pubmed: 26575988
Am J Hum Genet. 2016 Dec 1;99(6):1353-1358
pubmed: 27817866
EMBO Rep. 2003 Oct;4(10):976-81
pubmed: 12973300
mBio. 2019 Jun 18;10(3):
pubmed: 31213558
HLA. 2016 Nov;88(5):221-231
pubmed: 27620973
Cell Host Microbe. 2016 May 11;19(5):686-95
pubmed: 27173934
Traffic. 2005 Jun;6(6):429-41
pubmed: 15882441
J Acquir Immune Defic Syndr. 2010 Jul;54(3):241-7
pubmed: 20502347
Eur J Immunol. 2010 Apr;40(4):1036-41
pubmed: 20104487
Eur J Immunol. 2011 Jan;41(1):97-106
pubmed: 21182081
Nat Med. 2009 Aug;15(8):871-2
pubmed: 19648927
J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):172-8
pubmed: 26035050
Immunity. 1999 Jun;10(6):661-71
pubmed: 10403641
J Virol. 1998 Apr;72(4):2855-64
pubmed: 9525605
Scand J Immunol. 2002 Mar;55(3):221-8
pubmed: 11940227
J Virol. 2005 May;79(9):5489-98
pubmed: 15827163
Cell Host Microbe. 2009 Nov 19;6(5):409-21
pubmed: 19917496
J Virol. 2010 Nov;84(21):11279-88
pubmed: 20739527
Science. 2010 Dec 10;330(6010):1551-7
pubmed: 21051598
J Virol. 2018 Aug 16;92(17):
pubmed: 30115775
J Virol. 1994 Apr;68(4):2260-71
pubmed: 8139011
Retrovirology. 2013 Mar 20;10:32
pubmed: 23514615
Cell Rep. 2018 Feb 27;22(9):2493-2503
pubmed: 29490283
PLoS Pathog. 2018 Sep 4;14(9):e1007257
pubmed: 30180214
Blood. 2006 Nov 15;108(10):3414-9
pubmed: 16882705
PLoS Pathog. 2012;8(7):e1002805
pubmed: 22807681
Cell. 2010 Apr 30;141(3):392-8
pubmed: 20434978
J Immunol. 2012 May 1;188(9):4663-70
pubmed: 22474021
AIDS Res Ther. 2017 Sep 12;14(1):44
pubmed: 28893290
Immunogenetics. 2017 Aug;69(8-9):567-579
pubmed: 28695291
Virology. 2004 Sep 1;326(2):329-39
pubmed: 15321704
Immunogenetics. 2015 Aug;67(8):447-61
pubmed: 26129855
Genes Dev. 2004 Dec 1;18(23):2861-6
pubmed: 15574592
Science. 2007 Aug 17;317(5840):944-7
pubmed: 17641165
Science. 2013 Apr 5;340(6128):87-91
pubmed: 23559252
J Immunol. 2015 Apr 15;194(8):3594-600
pubmed: 25754738
J Gen Virol. 2004 Jul;85(Pt 7):1945-1954
pubmed: 15218179
J Virol. 2015 Oct;89(19):9781-90
pubmed: 26178989
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9230-4
pubmed: 15967992
Retrovirology. 2012 May 09;9:39
pubmed: 22571741
J Immunol Methods. 2015 Mar;418:9-18
pubmed: 25633660
AIDS. 1993 Nov;7(11):1411-7
pubmed: 7904166
Retrovirology. 2011 Dec 15;8:103
pubmed: 22171785
J Exp Med. 2001 Nov 5;194(9):1299-311
pubmed: 11696595
J Biol Chem. 2006 Jun 23;281(25):17259-65
pubmed: 16636053
J Virol. 2019 Sep 30;93(20):
pubmed: 31375574
Science. 2003 Nov 7;302(5647):1056-60
pubmed: 14564014
Virology. 2015 Aug;482:72-8
pubmed: 25827531
J Virol. 2006 Nov;80(21):10407-18
pubmed: 16956949
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18475-80
pubmed: 17132731
Sci Rep. 2017 Jan 04;7:40037
pubmed: 28051183
Virology. 2006 Jun 5;349(2):290-9
pubmed: 16530799
Retrovirology. 2013 Nov 18;10:138
pubmed: 24245672
J Immunol. 1998 Jan 1;160(1):171-9
pubmed: 9551969
Front Immunol. 2018 Dec 19;9:2978
pubmed: 30619335
J Virol. 2010 Jul;84(14):7378-95
pubmed: 20463079
Immunol Res. 1997;16(2):203-14
pubmed: 9212365
PLoS Pathog. 2012 Dec;8(12):e1003085
pubmed: 23300442
J Virol. 1993 Jan;67(1):438-45
pubmed: 7677956
Retrovirology. 2008 Aug 01;5:68
pubmed: 18673537
Nature. 2011 Aug 03;476(7358):96-100
pubmed: 21814282
J Virol. 2012 Mar;86(5):2715-28
pubmed: 22190722
J Virol. 2014 Sep 1;88(17):9893-908
pubmed: 24942576
Sci Rep. 2017 Dec;7(1):87
pubmed: 28273896
PLoS Pathog. 2012 Dec;8(12):e1003093
pubmed: 23308067
Nat Med. 2003 Nov;9(11):1398-403
pubmed: 14528301
J Virol. 2017 Feb 28;91(6):
pubmed: 28077643
J Clin Invest. 2012 May;122(5):1644-52
pubmed: 22505456
Cell Host Microbe. 2017 Jul 12;22(1):111-119.e4
pubmed: 28704647

Auteurs

Kristina Hopfensperger (K)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Jonathan Richard (J)

Centre de Recherche du CHUM, Montreal, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Canada.

Christina M Stürzel (CM)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Frederic Bibollet-Ruche (F)

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Richard Apps (R)

NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, USA.

Marie Leoz (M)

Normandie Université, UNIROUEN, UNICAEN, GRAM 2.0, Rouen, France.

Jean-Christophe Plantier (JC)

Normandie Université, UNIROUEN, UNICAEN, GRAM 2.0, Rouen University Hospital, Department of Virology, Laboratory Associated with the National Reference Center on HIV, Rouen, France.

Beatrice H Hahn (BH)

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Andrés Finzi (A)

Centre de Recherche du CHUM, Montreal, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, Canada.

Frank Kirchhoff (F)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Daniel Sauter (D)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany daniel.sauter@uni-ulm.de.
ORCID: 0000-0001-7665-0040

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD4+ › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Phénomènes biologiques › Évolution biologique › Évolution moléculaire › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Cellules › Cellules épithéliales › Cellules HEK293 › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Maladies du système immunitaire › Déficits immunitaires › Infections à VIH › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Virus › Virus à ARN › Retroviridae › Lentivirus › Lentivirus des primates › VIH (Virus de l'Immunodéficience Humaine) › VIH-1 (Virus de l'Immunodéficience Humaine de type 1) › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Virus › Virus à ARN › Retroviridae › Lentivirus › Lentivirus des primates › VIH (Virus de l'Immunodéficience Humaine) › VIH-2 (Virus de l'Immunodéficience Humaine de type 2) › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-C › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Phénomènes biologiques › Interactions hôte-microbes › Interactions hôte-pathogène › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines virales › Protéines des retroviridae › Protéines du virus de l'immunodéficience humaine › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Cellules tueuses naturelles › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Sous-populations de lymphocytes T › Lymphocytes T cytotoxiques › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines virales › Protéines virales régulatrices ou accessoires › Convergent Evolution of HLA-C Downmodulation...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines virales › Protéines virales régulatrices ou accessoires › Produits du gène vif › Produits du gène vif du virus de l'immunodéficience humaine › Convergent Evolution of HLA-C Downmodulation...